Medicare Drug Coverage Appeals May Follow Medicaid Model – McClellan

State Medicaid prior authorization procedures controlling the coverage of COX-2 inhibitors are a possible model for appeals processes under the Medicare drug benefit, Centers for Medicare & Medicaid Services Administrator Mark McClellan told the Senate Finance Committee